mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-07 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-06 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
7e-06 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
7e-06 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |